Drug intelligence / Profile preview

vitamin d

Development stage
Approved
Lead developer
Ghent University Hospital
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral
01

Overview

Vitamin D is a fat-soluble vitamin and steroid hormone precursor that functions as an agonist of the Vitamin D receptor (VDR). In the context of the PRIMMO Phase II clinical trial (NCT03192059) conducted by University Hospital, Ghent, Vitamin D is utilized as a key component of a five-drug immunomodulatory cocktail. This cocktail, which also includes aspirin, lansoprazole, low-dose cyclophosphamide, and curcumin, is administered to patients with advanced or refractory cervical cancer, endometrial cancer, or uterine sarcoma. The regimen is designed to modulate the tumor microenvironment by inhibiting myeloid-derived suppressor cells (MDSCs) and interleukin-6 (IL-6) production, thereby enhancing T-cell function and priming the immune system for treatment with pembrolizumab and stereotactic body radiation therapy (SBRT). Although the PRIMMO trial did not meet its primary efficacy endpoint, Vitamin D's role in this multimodal approach was to overcome immune resistance in gynecological malignancies.

Brand names
DrisdolCalciferolCarlson DDdropsDecaraDelta D3Enfamil D-Vi-Sol
Other names
cholecalciferolergocalciferolVitamin D3Vitamin D2
02

Targets

VDR (Vitamin D receptor)

Beyond the preview

Go deeper on vitamin d.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on vitamin d.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call